Start with our previous articles: FDAs Tirzepatide Shortage and Lawsuit Timeline December 2022: The FDA placed tirzepatide on its drug shortage list
5mg tirzepatide at 10mg/mL concentration: the most common scenario If you are using compounded tirzepatide, there is a good chance your vial is 10mg/mL
They have not been formally established for retatrutide because retatrutide is not yet FDA approved, and clinical trial protocols handle missed doses through site-specific procedures rather than published guidance
For compounded tirzepatide: Monthly: $299 per month (billed separately) 3-month plan: $249 per month 6-month plan: $229 per month For compounded tirzepatide microdoses: Monthly: $199 per month (billed separately) For compounded semaglutide: Monthly: $299 per month (billed separately) 3-month plan: $249 per month For compounded semaglutide microdoses: Monthly: $199 per month (billed separately) Other medications, such as Metformin ($90/3 months), Ozempic ($1,199/month) and Wegovy ($1,599/month), are also billed separately and are not included in the membership plans
Others prefer morning injections so they can monitor their response throughout the day
Every clinical trial Phase 1, Phase 2, and Phase 3 has used once-weekly dosing exclusively
